77 Pages

Nutrition

Course: MEDICINE 350, Winter 2007
School: Medical College
Rating:
 
 
 
 
 

Word Count: 3927

Document Preview

SEMINAR SEPTEMBER DM 23, 2005 NUTRITION IN ICU Navneet Singh Department of Pulmonary Medicine Scope of seminar Introduction Assessment of nutritional status Provision of nutritional support Enteral & Parenteral Nutrition Obesity & ICU Immunonutrition Nutrition Protocols Introduction Critical illnesses, stress & surgery place demands on bodys nutritional req. promote a catabolic...

Register Now

Unformatted Document Excerpt

Coursehero >> Georgia >> Medical College >> MEDICINE 350

Course Hero has millions of student submitted documents similar to the one
below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.

Course Hero has millions of student submitted documents similar to the one below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.
SEMINAR SEPTEMBER DM 23, 2005 NUTRITION IN ICU Navneet Singh Department of Pulmonary Medicine Scope of seminar Introduction Assessment of nutritional status Provision of nutritional support Enteral & Parenteral Nutrition Obesity & ICU Immunonutrition Nutrition Protocols Introduction Critical illnesses, stress & surgery place demands on bodys nutritional req. promote a catabolic state & -ve N balance. Prolonged bed rest & inactivity per se -ve N balance in healthy individuals Bloomfield SA. Med Sci Sports Exerc. 1997; 29(2): 197-206. Combination of hypermetabolic state like critical illness or sepsis + bed rest & inactivity suitable environment for occurrence of malnutrition Introduction Malnutrition - net nutrient intake < net nutrient req 1% to 15% of ambulatory outpatients 25% to 60% of institutionalized patients 35% to 65% of hospitalized patients Uncorrected it is succeeded by metabolic abnormalities, physiologic changes, reduced organ & tissue fx & loss of body mass OPTIMAL NUTRITIONAL STATUS & FACTORS INFLUENCING IT SE Status, Disease, Cultural Factors, Emotional Status Nutrient Intake Physio. Stress (Preg, Growth) Psychological Stress Path. Stress (Fever, Disease) Nutrient Requirements Disease Reduced Intake Losses (GI, Ur) Altered Requirements Deficiency Inefficient Fuel Utilization Reduced mass Change in Body Composition Change in Physiologic & Metabolic Responses Loss of reserve tissue & functional capacity Loss of Homeostasis Introduction Effect on Liver: Increased production of acute phase proteins Decreased production of albumin Increased catabolism of albumin Extravasation of albumin into extravascular space Effect on Lungs : Decreased diaphragmatic muscle mass Decreased max voluntary ventilation Decreased max mouth pressures Breathing pattern (Rapid shallow) Increased Fluid in Interstitium Decreased FRC & predisposition to atelectasis Introduction Feature BMR/REE Resp. Quotient Cytokine levels Primary fuels Proteolysis Ureagenesis Ur N losses Gluconeogenesis Ketone production Starvation (0.6-0.7) Fat + + + + +++ Catabolism in Critical Illness (0.8-0.9) Mixed +++ +++ +++ +++ + Introduction Demling RH, DeSanti L. Curr Opin Crit Care 1996; 2: 482491 Introduction Factors adversely influencing outcome in critical illness Depleted lean body mass Male gender Insulin insensitivity Impaired anti-oxidant defences Immunosuppression Hyper inflammatory state Ageing Disadvantageous genotype Grimble RF. Curr Opin Gastroenterol 2005; 21: 216222 Introduction Malnutrition in ICU patients can be either present on admission or develop subsequently as a result of metabolic response to injury Whatever the cause the end result is the same i.e. malnourished pts tend to have longer hospital LOS costs of care & mortality Middleton MH et al. Intern Med J. 2001; 31(8): 455-461. Nutritional suppl halt catabolism malnutrition opportunity to slow down or restore N balance prevent Nutritional Assessment Nutritional Assessment History: Medical (ch debilitating diseases & psy disorders) Socioeconomic Dietary/nutritional Drug abuse & alcoholism Physical Examination: Nutrition focused physical examination Anthropometry Body composition & circumference measurements Laboratory Investigations: Biochemical Immunologic Nutritional Assessment Body Weight: Unintentional loss of usual BW by >10% in 6 m (or >5% in 1 m) clinically significant & suggestive of malnutrition Problems with BW: Critically ill pts often edematous (water & salt retention) BW changes usually reflect fluid shifts & not changes in actual body cell mass Based on comparison with a wide range of N values compounded by presence of diversity in control population Nutritional Assessment 1. Ideal BW: comparison of ABW with IBW more useful than ABW alone IBW (M) = 106 lb for 5 ft height + 6 lb/ each addl inch IBW (M) = 47.3 kg for 150 cm height + 2.7 kg/ each addl 2.5 cm IBW (F) = 100 lb for 5 ft height + 5 lb/each addl inch IBW (F) = 44.6 kg for 150 cm height + 2.2 kg/each addl 2.5 cm Add or subtract 10% for large & small frames resp 2. BMI: Useful for grading malnutrition & prognostication Nutritional Assessment BMI (in kg/m2) Nutritional Status >30 Obese 25-30 Overweight 20-25 Normal <18.5 Mild & moderate malnutrition <16 Severe malnutrition <13 Usually incompatible with life (M) <11 Usually incompatible with life (F) Henry CG. BMI & limits of human survival. Eur J Clin Nutr 1990; 44: 329-335 Nutritional Assessment Anthropometric measurements: Objective evaluation of fat & LBM/skeletal proteins Safe, simple & inexpensive Can be done at bedside ? Reliability Accuracy of detecting ac changes esp critically pts who receive aggressive fluid resuscitation 1. Skinfold thickness Based on assumption that 50% of total body fat is s/c (vary from 20-70% in N subjects) Nutritional Assessment Commonly triceps used (subscapular/ iliac crest/ N values = 12.5 mm (M) & 16.5 (F) upper thigh) Over & under-estimation of body fat in malnourished & obese pts respectively 2. Mid upper arm circumference ( MUAC ): Mid-point b/w acromion & olecranon 3. Mid arm muscle circumference: = MUAC { x TSF } N values = 25.5 mm (M) & 23.0 mm (F) 4. W/H ratio Nutritional Assessment Serum Albumin Serum half life 20 d Neither sensitive nor specific as a std for nutritional assessment In addition to nutritional status, affected by: Hepatic fx Protein loss Hydration status Changes in distribution b/w intra & extravascular compartments incl exudation at the capillary level Infection/infl Better marker of disease severity than nutritional status? Nutritional Assessment Serum Albumin Hypoalbuminemia an imperfect measure of nutrition but an excellent marker of injury? Levels indicate catabolism (cytokine mediated) Levels correlate inversely with other markers of infl Rate of fall may be as high as 50% in 2 d of ac phase of sepsis & can relate to mortality Levels not expected to despite nutritional intake unless stress response subsides Attempts at correction of hypoalbuminemia by i/v admn of albumin not assoc with improved clinical outcomes Serum proteins in critical illness Fleck A. Br J Clin Pract Suppl 1988;63:204; Nutritional Assessment Serum Albumin Control of stress levels can by upto 10%/ day with adequate nutr support may be N by 2 wks However despite the concerns regarding its usefulness, serum albumin remains one of the most powerful nutritional markers & outcome predictors in hospitalized patients & critical illness Lafrance JP et al. Metabolic, Electrolytes & Nutritional Concerns in Critical Illness. Crit Care Clin 2005; 21: 305327 Nutritional Assessment ALC: Levels <1000/uL ? depletion of T cell rich areas of RES & assoc with cutaneous anergy Pre albumin: Produced primarily in liver (others choroid plexus & enterochromaffin cells in GI mucosa) Normal levels: 6 to 35 mg/dl ? Better marker of malnutrition Short serum t (2 days) Less affect by liver disease than other proteins Not affected by hydration status Not affected by vitamin deficiency (except zinc) Negative acute phase reactant Nutritional Assessment SGA (Subjective Global Assessment): Based on assumption that history/physical exam assesses nutritional status more precisely & is better predictor of morbidity/mortality than any lab test History: Physical Exam: Wt change Dietary intake change ( ~ N) GI symp (> 2 wks) Functional capacity Loss of s/c fat Muscle wasting Ankle & sacral edema Ascites Nutritional Assessment Divided into Class A :< 5% wt loss or > 5% wt loss + recent gain & improvement in appetite Class B : 5-10% wt loss without recent stabilization or gain, poor dietary intake & mild loss of s/c tissue Class C: ongoing wt loss of >10% with severe s/c tissue loss & muscle wasting often with edema Other Nutritional Indices: Prognostic Nutritional Index (PNI) combines measurements of S. Albumin, S. Transferrin, TSF Thickness & Delayed Cutaneous Hypersensitivity Prognostic Infl & nutritional index (PINI) aggregates S. levels of CRP, alpha 1-acid glycoprotein, prealbumin & albumin Nutritional Assessment No single marker till date has been validated as being ideal for assessing nutritional status of critically ill patients i.e. there is no gold std: No universally accepted clinical definition of malnutrition All currently available parameters for assessment of nutritional status are affected by disease processes Effects of malnutrition & of the disease itself on the final outcome may be difficult to distinguish There is paucity of data to compare different commonly used nutritional assessment parameters and hence sensitivity, specificity and reliability of each vis--vis others cannot be defined Klein S et al. J Parenter Enteral Nutr 1997; 21: 133-156 Provision of Nutritional Support Provision of Nutritional Support Goals/Principles of Nutr. Support to critically ill: Provision of nutr support after taking into account: Medical condition Baseline nutritional status Existing metabolic requirements Route available for admn of nutrients (EN and/or PN) Prevention (if possible) of nutrient deficiencies (macro & micro) & Rx of existing ones Avoidance of complications associated with nutritional support Improvement in pt outcomes (morbidity/mortality) Provision of Nutritional Support Indications Presence of malnutrition (of any etiology) in a patient unable to eat (Benefit of nutritional support best seen in pts whose baseline nutritional status is < N incl pts with BMI<16) In well-nourished pts, prolonged fasting (>3-4 d) & inability to resume oral nutrition (Such pts can often tolerate short periods of starvation <1 week) Supplementation if oral intake insufficient for >3-4 d Provision of Nutritional Support Sys review, 15 prospective RCTs, n=753 Adult ICU pts (post-op, trauma, head-injury & burns) - No study on MICU pts Compared early EN (initiation of nutr support in < 36 hrs) to delayed EN (>36hrs) Early EN assoc with: infection rates (RR = 0.45) Hosp LOS mortality (8% vs 11.3%, RR=0.74 NS) No diff w.r.t non-infectious complications Marik PE et al. Crit Care Med 2001; 29(12): 2264-2270 Provision of Nutritional Support Calories: TEE = REE x activity factor REE (BMR): Harris-Benedict equation Males = 66.5 + 13.75W + 5.003H 6.775A Females = 655.1 + 9.563W + 1.850H 4.676A W = Wt in kg, H = Ht in cm & A = age in yrs Males = 25 kcal/kg OR 900 + 10 x weight (kg) Females = 22 kcal/kg OR 700 + 7 x weight (kg) 10%/C rise in temp by 40 100% Sepsis Starvation by 20 40% Fever Provision of Nutritional Support Activity factor: 1.2 (sedentary), 1.4 (moderate) & 1.8 (heavy) Indirect calorimetry: Measures REE from O2 consumption (VO2) & CO2 production (VCO2) in specified time period REE (kcal/min) = C.O. x VO2 + 1.1 VCO2 REE (kcal/d) = REE (kcal/min) x 1440 Protein: 1.2-1.5 g/kg BW/d (max 1.8-2.0 g/kg BW/d in pts with extreme protein losses Fluid: Approx 1 ml of water per kcal administered Enteral & Parenteral Nutrition Enteral & Parenteral Nutrition Whenever nutritional supplementation is indicated, EN preferred to PN Advantages of EN over PN: incidence of mucosal atrophy & reduction in intestinal permeability Promotes gut motility paves way for initiation of oral feeding translocation of bacteria from the gut Avoids infectious complications assoc with PN Less costly More physiological Jolliet P et al. Intensive Care Med 1998; 24: 848-859 Enteral & Parenteral Nutrition Contraindications to EN: Absolute Nonfunctional gut: anatomic disruption, obstruction, gut ischemia Generalized peritonitis Severe shock states Relative Expected short period of fast, except in severely injured patients Abdominal distension during EN Localized peritonitis, intra-abdominal abscess, severe pancreatitis Early EN vs Early PN Meta-analysis of trials comparing early EN vs early PN in hospitalized pts 30 RCTs (10 medical, 11 surgical & 9 trauma) No diff b/w groups in terms of hospital mortality (applicable for subgroups also) PN incidence of infective (incl CRBI) & noninfective complications & Hosp LOS EN assoc with in diarrhea No effect of age, time to initiate Rx & av albumin on mortality Early EN ~ early PN does not mortality Peter JV et al. Crit Care Med 2005; 33(1): 213-220 Enteral vs Parenteral Nutrition Meta-analysis of 11 trials (complete F/U in 9) of PN vs. EN in critically ill pts Analysis based on intention to treat principle Mortality benefit in favour of use of PN; subgroup analysis benefit from PN use greatest in trials in which EN delayed (>24 hr) Infectious complications increased with PN (6/9) Grade B+ EB recommendation for PN use in pts in whom EN cannot be initiated within 24 hr of ICU admission or injury Simpson F et al. Intensive Care Med 2005; 31: 1223 Enteral vs Parenteral Nutrition Sys Review,13 RCTs, n=807 Compared EN vs PN for outcome of critically ill adult pts Heterogeneous population of ICU pts (head trauma & injury, abd trauma, sepsis, cardiac bypass or severe ac pancreatitis) Use of EN ~ PN assoc with in infectious complications (RR = 0.64) in cost No diff in mortality, MV duration or hosp LOS Gramlich L et al. Nutrition 2004;20:843 848 Enteral vs Parenteral Nutrition PN assoc with: incidence of hyperglycemia caloric intake (5/11) No diff in mortality rate b/w pts on PN & BS vs pts on EN & N BS Data on baseline nutritional status NA no conclusion on its relation with outcome EN should be the first choice for nutritional support in the critically ill Gramlich L et al. Nutrition 2004;20:843 848 Enteral + Parenteral Nutrition Sys review, 5 RCTs, n=248, ICU (M + S), Burns & Blunt Trauma pts Compared EN + PN to EN alone (PN started at same time as EN) No diff b/w groups w.r.t mortality, rates of infection, Hosp LOS or MV duration + EN PN significant in cost & calorie delivery In critically ill patients who are not malnourished and have an intact gastrointestinal tract, starting PN at the same time as EN provides no benefit in clinical outcomes over EN alone Dhaliwal R et al. Intensive Care Med 2004; 30: 16661671 Enteral & Parenteral Nutrition PN remains a valuable yet challenging weapon in our therapeutic armory in the presence of GI feed intolerance or failure. However it should be used wisely & not indiscriminately because most intensive care patients with a fully functional GIT may be fed safely with EN Griffiths RD. Curr Opin Clin Nutr Metab Care 2004; 7:175-181 Obesity in ICU Predicting energy needs in critical illness difficult (uncertainties reg influence of diff factors on EE) much more difficult in critically ill obese pts Although morbidly obese patients have excess body fat stores, they are prone to develop protein malnutrition during metabolic stress basal insulin level suppression of lipid mobilization from body stores acc protein breakdown for gluconeogenesis rapid in lean body mass (LBM) & in urea prod & Ur N losses Jeevanandam M et al. J Clin Invest 1991; 87: 262269 Obesity in ICU Effect of obesity on ICU mortality Retro study (n=117, 2 MICUs) Morbidly obese pts (BMI>40) had req for MV, MV duration, ICU LOS & overall mortality (30% vs 17%) El-Sohl A et al, Chest 2001; 120:19891997 Prospective study (n = 813, single center) BMI of 27 used to separate obese (n = 215) & nonobese (n = 598) groups Obese pts had higher ICU LOS, SAPS II score & ICU mortality. Observed mortality of obese pts > mortality predicted by SAPS II scores Obesity in ICU Multivariate analysis SAPS II score & BMI > 27 predictive of ICU mortality Current prognostic scoring systems do not include BMI/obesity though high BMI value is an independent predictor of high ICU mortality These underestimate the mortality risk for obese patients Goulenok C et al. Chest 2004; 125: 14411445 Prospective study (n= 2148) No effect of BMI on APACHE II scores, mortality, ICU LOS, hospital LOS, % req MV, days on MV, total cost or adverse events BMI has minimal effects on ICU outcome Ray DE et al. Chest 2005; 127: 21252131 Obesity in ICU SUPPORT (Study to Understand Prognoses & Preferences for Outcomes & Risks of Rx) Prospective, multicenter study (n = 4301) 5 tertiary care medical centers Pts >18 yrs + anticipated 6 m mortality = 50% BMI <15th percentile assoc with 6 m mortality (risk ratio = 1.23) High BMI (>85th percentile) not assoc with significantly risk of mortality Galanos AN et al. Crit Care Med 1997; 25:1962-1968 Obesity in ICU Retrospective analysis (n = 41011, Multicenter) Divided into 2 groups depending whether SAPS II or mortality prediction model [MPM] used Underweight (BMI <20) mortality + ICU & hospital LOS + Impaired fx status at discharge Overweight (BMI = 25-30) disability at discharge Obese (BMI = 30-40) ICU & hospital LOS (SAPS) BUT disability at discharge (MRM) ICU & hospital LOS Severely obese (BMI > 40) Overweight & Obese Pts may have mortality & improved functional status at discharge Tremblay A et al. Chest 2003; 123: 12021207 Obesity in ICU Which weight to use? ABW vs IBW 65 hospitalized & 65 non hospitalized obese adults (ABW >130% IBW, ~ all pts on EN/PN) EE predicted better by using ABW ~ IBW Ireton Jones et al. J Am Diet Assoc 1991; 91: 93-95 Obesity Adjusted Wt (OAW) Developed for more accurate prediction of LBM in obese pts OAW = IBW + 0.25 (ABW IBW) Obesity in ICU OAW vs ABW Energy needs predicted with Harris-Benedict equation (HBE) & kJ/kg (KPK) strategies (using both ABW & OAW) Results compared with measured EE determined by indirect calorimetry Use of ABW overfeeding Use of OAW + KPK strategy more accurate energy predictions ~ HBE OAW + KPK strategy preferable for obese pts ( 130% of IBW) Cutts ME et al. Am J Clin Nutr 1997; 66: 12501256. Obesity in ICU Eucaloric vs hypocaloric EN 40 critically ill, obese pts admitted to trauma/SICU (ABW > 125% of IBW) Eucaloric feeding ( 20 kcal/kg/d of OAW) or hypocaloric feeding (>20 kcal/kg/d of OAW) Protein intake for both ~ 2 g/kg/d (IBW) Hypocaloric group: Shorter ICU LOS Duration of Antibiotic Rx Duration of MV (NS) Dickerson RN. Nutrition 2002; 18(3): 241-246. Obesity in ICU Indirect calorimetry to determine EE : Req FiO2 <0.6 Erroneous values: System leaks Abnormal water vapor pressure Errors in calibration Current recommendation: OAW + KPK strategy 20 30 kcal/kg/d (OAW) 1.52.0 g/kg/d (IBW) El-Solh AA. Am J Respir Crit Care Med 2004; 169: 557561 Immunonutrition Immunonutrition Nutritional deficits produce significant atrophy of lymphoid organs & impaired fx Malnutrition (& impaired immune fx) common in hospitalized patients adverse effect on recovery The administration of nutrients that have nutritive and pharmacological effects (immunonutrition) can counteract this and improve patient outcome Immunonutrients are specific nutrients that exert immune enhancing effects independent of their energy/protein value (include arginine, glutamine, nucleotides & -3 FA) Immunonutrition -3 FA + med chain TGs + olive oil alt to -6 FA (pro-infl effects) as I/V lipid suppl Oxidative fuel for lympho & macro. During stress, exogenous glutamine reqd to avoid catabolism & muscle glutamine depletion Stimulation of macrophages & NK cells fx Grimble RF. Immunonutrition. Curr Opin Gastroenterol 2005; 21: 216222 Antioxidants/-3 FA & Oxidative/Inflammatory Stress Grimble RF. Immunonutrition. Curr Opin Gastroenterol 2005; 21: 216222 Immunonutrition Linoleic acid 6 PUFA Major constituent of cell membranes Precursor of prostanoid & LT synthesis No parenteral forms available Trace Elements Zinc reqd for biologic activity of thymic hormone (T cell maturation) Def assoc with intractable infections Copper Effects on T & B cell function Selenium def Ab responses Other trace elements & antioxidants shown in vitro to modulate activity of various immune cells Slone DS. Crit Care Clin 2004; 20: 135157 Immunonutrition What is clear about Immunonutrition?: Efficacy better when admn through EN > PN Efficacy better when admn to malnourished pts What is unclear? Is it efficacious at all? Immunonutrition Meta-analysis, 11 RCTs, n=1009 Comparison of EN + key nutrients vs std EN in pts with critical illness & cancer Results: in infectious complications hosp LOS No diff in mortality No diff in incidence of pneumonia Heys SD et al. Ann Surg. 1999; 229(4): 467-77 Immunonutrition Outcome Mortality Infection Hosp LOS No of trials Overall Medical 12 3 8 1 10 2 Effect of ImN Overall Medical NS NS NS S HS S ICU LOS 6 2 NS NS Days on MV 5 2 NS S Comparison of outcome with std EN vs commercially available immune-enhancing EN feeds (arginine glutamine, nucleotides & -3 FA) in critically ill pts after trauma, sepsis or major surgery Sys review (12 RCTs, n=1482), analysis on intent-to-treat basis Beale RJ et al. Crit Care Med 1999; 27:2799-2805 Immunonutrition Outcome Mortality Infection Hosp LOS No of trials Overall Medical 22 13 18 9 17 8 Effect of ImN Overall Medical NS NS NS S S S Comparison of outcome of std EN vs EN + immune enhancing nutrients in pts of elective surgery & critically ill pts after trauma, burns or in ICU, Sys review (22 RCTs, n=2419) Use of formulas other than high arginine content mortality & hosp LOS (overall & critically ill pts) infection (overall) Use of high arginine content formulas & hosp LOS (overall & critically ill pts) Heyland DK et al. JAMA 2001; 286: 944-953 Immunonutrition Sys review of effects of std EN vs diets enriched with pharmaconutrients 26 RCTs surgical (9), trauma (7), burns (2) & mixed/ICU (8) n=? Overall: Pts in pharmaconutrition group had Incidence of HAP (11, OR=0.54) Incidence of bacteremia (9, OR=0.45) MV duration (7), ICU LOS (8) & Hospital LOS (12) No diff in mortality (18) overall & subgroup analysis No diff in incidence of sepsis (5) or UTI (10) Montejo JC et al. Clin Nutr. 2003; 22(3): 221-233 Immunonutrition No e/o total no of infected pts during ICU stay (ONLY incidence of some infections in some groups) Mixed group No MV duration, Hosp LOS or ICU LOS in pharmaconutrient group Marked heterogeneity in patient characteristics as well as methodology/designs of trials Considering some beneficial effects & absence of detrimental ones, these diets could be recommended in ICU pts requiring EN (Grade B recommendation) Montejo JC et al. Clin Nutr. 2003; 22(3): 221-233 Immunonutrition Prospective DB RCT 2 ICUs, Netherlands Heterogeneous population of pts expected to require EN > 48 hrs (n =597) Randomized to receive Immunonutrition (highprotein enteral formula enriched with arginine, glutamine, 3-FA & antioxidants) or an isocaloric control formula Intention to Rx analysis Kieft H et al. Intensive Care Med. 2005; 31(4): 524-532 Immunonutrition No diff b/w groups w.r.t.: Hosp LOS ICU LOS MV duration ICU mortality Hosp mortality Infectious complications Largest RCT on immunonutrition in a general ICU population immunonutrition has no beneficial effect on clinical outcome parameters Kieft H et al. Intensive Care Med. 2005; 31(4): 524-532 Immunonutrition Q: Why is there so much variability in responsiveness to immunonutrition? A: Genes for cytokines & other molecules that influence infl may be affected by changes in their promoter regions [single nucleotide polymorphisms (SNP)] diff in amount of gene formed when activation occurs. In addition to diff in pt profiles, SNPs may be an imp factor determining efficacy & clinical outcomes of immunonutrition studies reqd to determine exact nature of genomic factors that influence immunonutrition Immunonutrition Reports of infl could counteract effect on immunity & could even make overall responses to immune enhancing diets harmful Effects are potentially unpredictable in different clinical settings Avoid extrapolation of results between disparate groups Routine use of immune-enhanced formulas cannot be recommended without further research to define the underlying mechanisms by which immunonutrition may be harmful & to identify which ingredients have beneficial effects Nutrition Protocols Nutrition Protocols Pros: Era of EBM Use of guidelines, clinical protocols & recommendations improved quality of care (esp in critical care single intervention dramatic consequences & amount of available info > human decision-making limits) Cons: Shortage of large prospective RCT limitation in stringency of recommendations ? Compliance with tight stds of care Imposition of cookbook medicine hampered freedom of Mx of pts Anorexia Protocolis (reluctance to use protocols) Zaloga et al. Chest 2004 ; 125 : 11951196 Nutrition Protocols Prospective observational study Canada, 59 ICUs (n = 638) Hypothesis: ICUs whose practice was more consistent with guidelines would have greater success in providing EN Pts on MV > 48 hrs & ICU stay > 72 hrs Av duration of observation 10 d Adequacy of EN (received/prescribed calories) = 1.8-76.6% (av 43%) Heyland DK et al. Crit Care Med 2004; 32(11): 2260-2266 Nutrition Protocols Higher adequacy of EN assoc with: Use of a feeding protocol Early initiation of EN (>50% of pts within 1st 48 hrs) Use of small bowel feedings or motility agents in >50% of pts with high gastric residual vol Inverse assoc with use of PN (> median) Study confirmed hypothesis: ICUs that are more consistent with clinical practice guidelines are more likely to successfully provide EN support to pts could lead to better outcomes Heyland DK et al. Crit Care Med 2004; 32(11): 2260-2266 Nutrition Protocols Prospective study USA, MICU/SICU of 2 teaching hospitals Objective: To determine effect of implementation of an EB nutritional Mx protocol in ICU Included all pts with expected ICU stay > 48 h n= 200, 100 pts in each group (before & after implementation of protocol) Pts in postimplementation group: Fed more frequently via enteral route (adjusted OR = 2.4) Shorter duration of MV Barr J et al. Chest 2004; 125: 14461457 Nutrition Protocols No diff between two groups: Time to initiate feeding Total caloric intake on d 4 of nutritional support ICU LOS Hospital LOS Pts who received EN had risk of death (HR = 0.44) Barr J et al. Chest 2004; 125: 14461457 Nutrition Protocols ACCEPT (Algorithms for critical care enteral & parenteral therapy) Trial Multicentre, cluster RCT (n = 462) Hypothesis: Use of EB algorithms for providing nutritional support in ICU improvement in pt outcomes ICUs of 12 hospitals Pts 16 yrs & expected ICU LOS > 48 hrs ICUs stratified by hospital type & randomized to intervention or control arms Martin CM et al CMAJ 2004; 170(2): 197-204 Nutrition Protocols Pts in intervention hospitals: Received nutritional support on more no of days (EN or EN/PN) Had shorter hospital LOS Had reduced mortality No diff in: ICU LOS Time to initiate nutritional support Total calories or protein delivered No of days on which caloric goal achieved Martin CM et al CMAJ 2004; 170(2): 197-204 Nutrition Protocols Q: What if nutritional protocols are not established? A: Daily assessment of whether a pt can be fed, in what way (EN/PN/mixed) and how much? All health care professionals involved in care of ICU pts (physician, nurse, dietician, physiotherapist etc) should be involved in Mx of nutritional support even when their levels of interest and knowledge widely differ Preiser JC et al. Crit Care Med 2004; 32(11): 2354-2355. Summary Nutrition is a very imp aspect of pt care in ac & ch critical illnesses Use of appropriate nutritional support is cost effective by reducing complication rates & duration of stay EN confers an enormous financial advantage over PN Optimal nutritional support to prevent & Rx nutritional deficiencies should become part of routine Mx of ICU pts
Find millions of documents on Course Hero - Study Guides, Lecture Notes, Reference Materials, Practice Exams and more. Course Hero has millions of course specific materials providing students with the best way to expand their education.

Below is a small sample set of documents:

Medical College - MEDICINE - 350
DM SEMINARAugust 18, 2006Organophosphate poisoning: current managementstrategies.R.SRINIVASDepartment of Pulmonary MedicineOrganophosphate poisoning: Magnitude of problem.WHO estimates acute pesticide poisonings at 3 million cases/ year.I million
Medical College - MEDICINE - 350
Obstructive sleep apnea : recentadvances and future trendsAjay HandaDept of Pulmonary MedicineSleep physiologyHistorical aspectsClinical profilePolysomnographyManagementRecent advancesFuture directionsSleep physiology Sleep is a period of bodi
Medical College - MEDICINE - 350
Oxidative stress inhealth and diseaseCurrent role of antioxidantsin lung diseasessDr. Alok NathDepartment of Pulmonary Medicine and Critical CarePGIMERChandigarhWhere to startQuestions arising in our minds ?What are free radicals ?What are rea
Medical College - MEDICINE - 350
Pulmonary hypertensionCurrent perspectives in the diagnosisand managementChandanaSenior Resident, Dept. of Pulmonary medicinePGIMERDefinitionClassificationPathobiologyDiagnosisTreatmentEvianNomenclatureandClassificationofPulmonaryHypertension
Medical College - MEDICINE - 350
Current and EmergingDrugs in PulmonaryVascularPharmacologyDr AS PaulDM Seminar08 September 06Pulmonary HypertensionA mean pressure of greater than 25 mmHg at rest (normal ~14 mm Hg) or greaterthan 30 mm Hg during exercise.At restsustained vaso
Medical College - MEDICINE - 350
Pathophysiology ofhypercapnic and hypoxicrespiratory failure and V/QrelationshipsDr.Alok NathDepartment of Pulmonary MedicinePGIMERChandigarhJan 2006Respiratory Failureinadequate blood oxygenation or CO2 removalA syndrome rather than a disease
Medical College - MEDICINE - 350
SARCOIDOSISCurrent Controversies&amp;Update of SarcoidosisPATHOGENESIS :Antigen Triggered :Evidence : Multisystem granulomatous disorder of unknown origincharacterized by activation of T-Lymphocytes andmononuclear phagocytes at sites of disease. Mos
Medical College - MEDICINE - 350
IntroductionSMALL CELL LUNGCANCERCurrent Controversies &amp;Update in ManagementDr. Zia HashimOctober 29,2004Small cell lung cancer (SCLC) was initially recognizedSmallas an entity distinct from other types of lung cancerby pathologic examination in
Medical College - MEDICINE - 350
Sedation in the ICU-drugs, regimens ofadministration and monitoringR. SrinivasSenior Resident, Dept. of Pulmonary medicinePGIMER22 September 2006.Sedation in the ICU-why bother?1.To relieve Dyspnea and intractable coughing2.For amnesia during crit
Medical College - MEDICINE - 350
DM SEMINARFEBRUARY 04, 2005T H O R A C O S C O P Y (ME DIC A LA N D VIDEO A S SIST E DS U R G ICAL)NAVNEET SINGHDEPARTMENT OF PULMONARYMEDICINEHEADINGS INTR O D U C TIO N M E DICAL T H O R A C O S C O P Y V S V A T S INDICATION S C O N T R A-I
Medical College - MEDICINE - 350
DM SEMINARMARCH 11, 2005STAGING PROCEDURESFOR LUNG CANCERNAVNEET SINGHDEPARTMENT OF PULMONARYMEDICINESCOPEINTRODUCTIONNON-INVASIVE PROCEDURESINVASIVE PROCEDURESPRIORITIZATION OF PROCEDURESPROBLEM SOLVINGINTRODUCTIONSteps in W/U of Suspected
Medical College - MEDICINE - 350
SURFACTANT INHEALTH AND DISEASEDR. AMIT RAODEOINTRODUCTIONLung epithelium is in close contact with environment-actsas barrier.Appropriate balance between pro and anti inflammatoryresponse is critical.Airspace lined with a lipoprotein complex calle
Medical College - MEDICINE - 350
SWAN GANZ CATHETERSIntroduction Introduced by Swan &amp; associated in 1970 Balloon tipped, flow directed catheters Rationale for use: Clinical observation subjective/inadequate in criticallyill Allow measurements of determinants &amp; consequencesof card
Medical College - MEDICINE - 350
CURRENT CONCEPTS INMANAGEMENT OFTUBERCULOSISEVOLUTION OF DRUG THERAPYPre Streptomycin era: Rest - Sanatorium/Affected portion of lung- Collapse therapy Use of Gold Salts/Sulphones/Vit D50% Mortality - PTBSM:MRC Trial, 1946104 PatientsSMBed Re
Medical College - MEDICINE - 350
DM SEMINARFEBRUARY 27, 2004OXYGEN - CARBON DIOXIDETRANSPORTNAVNEET SINGHDEPARTMENT OF PULMONARYAND CRITICAL CARE MEDICINEPGIMER CHANDIGARHHEADINGS INTRODUCTION OXYGEN TRANSPORT FROM LUNGSTO CELLS OXYGEN DELIVERY DURINGEXERCISE OXYGEN DELIVER
Medical College - MEDICINE - 350
TROPICAL MEDICINE FOR THEPULMONOLOGIST(MALARIA,HYDATIDDISEASE,AMOEBIASIS,LEPTOSPIROSIS)DR.AMIT RAODEOMALARIA1INTRODUCTIONMalaria remains a major public health problem in endemicMalariaareas.Responsible for 1.5 to 2.7 million deaths each year wor
Medical College - MEDICINE - 350
UNCOMMON INTERSTITIALLUNG DISEASESDr. Zia HashimDepartment of Pulmonary &amp; Critical Care MedicinePGIMERChandigarhPulmonary Langerhans CellHistiocytosisDefinition Forms part of a spectrum of diseasescharacterized by monoclonal proliferation andin
Medical College - MEDICINE - 350
DM SEMINARFEBRUARY 3, 2006The Pulmonary VasculitidesR.SRINIVASDepartment of Pulmonary MedicinePulmonary vasculitis-an classification perspective:The vasculitides are a group of clinically diverse conditions charac. byinvolvement of blood vessels in
Medical College - MEDICINE - 350
New Modes of VentilationDr. Zia HashimModeDescribes the specific combination of:controlphaseconditional variablesDefined forspontaneousmandatory breathsVariableControl variable : Constant throughoutinspiration, regardless of changes inrespira
Medical College - MEDICINE - 350
Physiology of ventilation &amp;work of breathingPuneet MalhotraDept. of Pulmonary Med, PGIMER20.03.04Goals of respiration1.Ventilation2.Diffusion of O2 &amp; CO23.Transport of O2 &amp; CO24.Regulation of respirationVentilation Movement of air in &amp; out of l
BYU - BIO - 119
Metabolism LecturesOutline: Part I: Fermentations (Monday) Part II: Respiration (Wednesday) Part III: Metabolic Diversity (Friday)Learning objectives are: Learn about anaerobic respiratory metabolisms. How can an inorganic compound be use as an ene
BYU - BIO - 119
Figure 13.9 Initiation and elongation steps of transcriptionFigure 13.10 Alternative sigma () factors of Escherichia coli and Bacillus subtilis and theircognate promoter sequencesFigure 13.18 Overview of the three stages of protein synthesisFigure 13.
BYU - BIO - 119
Transcription/Translation/Protein SecretionBio119I. TranscriptionA. Many bacterial genes are arranged in operons1.2. They are transcribed together3. An operon of genes shares a:4. This increases efficiency in gene expression and regulationof a par
BYU - BIO - 119
Mutations in bacteriaBio119I. Mutations: what are they?A. They are changes in the DNA sequenceB. Can arise:C. Consequences of mutations in a haploid genome:D. If mutation is not repaired before next round of replication:E. Revision to wild-type is
BYU - BIO - 119
Study Questions: Mutations Part I 1) What is a point mutation? What is the difference between a silent mutation, a nonsense mutation and a missense mutation? 2) What effect would a single base pair deletion within a gene coding sequence have on the result
BYU - BIO - 119
Study questions for Regulation 1) Why do organisms have so many genes if they don't even express them all at once? 2) How is the lac operon regulated? Why aren't the lac genes always transcribed? How does the regulator work? What would happen to lac opero
BYU - BIO - 119
A n tib io tic s a n d R e s is ta n c eT O P IC S1.2.3.4.5.6.A n tib io tic s a n d c lin ic a l m ic r o b io lo g yT y p e s o f a n tib io tic sM e c h a n is m s o f a c tio nT e s t fo r a n tib io tic s e n s itiv ityA n tib io tic r e
BYU - BIO - 119
Virus (Latin: slimy toxin, venom) Edward Jenner English, 1798We say viruses, plural but actually should be viri=infectious agent you could pass through a 0.2um (micrometer) filter Beijerinick 1899I. Virus - An acellular obligate intracellular parasite
BYU - BIO - 119
420Multiple pathways allow protein secretion across the bacterialouter membraneDavid G Thanassi* and Scott J HultgrenSecretion of proteins across the bacterial outer membranetakes place via a variety of mechanisms from simple onecomponent systems to
NE Texas CC - BIO - 101
BIOCHEMISTRY OF THE MOLECULES OF LIFEREAD CH. IN TEXT: Review the characteristics of the biological molecules carbohydrates, proteins, and lipids.Biological MoleculesInorganic compounds 1. Usually lack carbon 2. Generally dissolve in water or dissociat
University of Alberta - BUS - 301
The University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, X1Professor:Office:Classroom:Office Hours:Telephone:Class Time:Telephone:Website:E-Mail:Fall Term 1999Ross G. Bradford4-21C Bus
University of Alberta - BUS - 301
The University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, X1Professor:Office:Classroom:Office Hours:Telephone:Class Time:Telephone:Website:E-Mail:Fall Term 2000Ross G. Bradford4-21C Bus
University of Alberta - BUS - 301
The University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, A1Professor:Office:Classroom:Office Hours:Telephone:Class Time:Telephone:Website:E-Mail:Spring Term 2000Ross G. Bradford4-21C B
University of Alberta - BUS - 301
I. INTRODUCTION(A)THE CANADIAN CONSTITUTION (Read pp. 24-32)(1)(2)(3)(4)(5)(B)Parliamentary SovereigntyRule of LawResponsible GovernmentDivision of Powers Between Federal and Provincial GovernmentsConstitution Act 1867 and Constitution Act 19
University of Alberta - BUS - 301
I. INTRODUCTION(A)THE CANADIAN CONSTITUTION (Read pp. 24-32)(1)(2)(3)(4)(5)(B)Parliamentary SovereigntyRule of LawResponsible GovernmentDivision of Powers Between Federal and Provincial GovernmentsConstitution Act 1867 and Constitution Act 19
University of Alberta - BUS - 301
The University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, X5Professor:Office:Classroom:Office Hours:Telephone:Class Time:Telephone:Website:E-Mail:Winter Term 2000Ross G. Bradford4-21C B
University of Alberta - BUS - 301
The University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, X1Fall Term 2001Ross G. BradfordM 6:30 9:20 p.m.BUS 1-05Room 320C Business Building(780) 492-5819(780) 492-3325Ross.Bradford@ualbert
University of Alberta - BUS - 301
The University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics and LawBUSINESS LAW 301, A1Intersession Spring Term 2001Ross G. BradfordMTWRF 10:30 11:40BUS 1-054-21C Business Building(780) 492-5819(780) 492-3325Ross.Bra
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics and LawBLAW 301 LEGAL FOUNDATIONS OF THE CANADIAN ECONOMYFall 2008Instructor: Jacob J. ShelleyLEC A2:MWF 09:00-09:50 (BUS 2 5)LEC A3:MWF 10:00-10:50 (BUS 2 9)LEC
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics and LawBLAW 301 LEGAL FOUNDATIONS OF THE CANADIAN ECONOMYFall 2008Instructor: Jacob J. ShelleyLEC A2:MWF 09:00-09:50 (BUS 2 5)LEC A3:MWF 10:00-10:50 (BUS 2 9)LEC
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics and LawBLAW 301 LEGAL FOUNDATIONS OF THE CANADIAN ECONOMYFall 2008Instructor: Jacob J. ShelleyLEC A2:MWF 09:00-09:50 (BUS 2 5)LEC A3:MWF 10:00-10:50 (BUS 2 9)LEC
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2009Instructor:LECA2Office:Telephone:Email:Jeffrey Bone (B.A., LL.B.)MWF 10:00-10:50 BUS 2 9TBATBATBACourse Objectives:1. To introduce students to the Canadian legal system.2. To
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2009Instructor:LEC A4:Office:Telephone:Email:Jeffrey Bone (B.A., LL.B.)MWF 12:00-12:50 BUS 3 5TBATBATBACourse Objectives:1. To introduce students to the Canadian legal system.2.
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2009Instructor:LEC A5:Office:Telephone:Email:Jeffrey Bone (B.A., LL.B.)T R 3:30 - 4:50 BUS 1 5TBATBATBACourse Objectives:1. To introduce students to the Canadian legal system.2.
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2010Instructor: Jeffrey Bone, Barrister &amp; SolicitorLEC A1:MWF 8:00 8:50 BUS 2 5Office:2-33Office Hours: Monday &amp; Wednesday 2: 00 3: 30 pmEmail:jjbone@ualberta.caSo much of the time w
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2010Instructor: Jeffrey Bone, Barrister &amp; SolicitorLEC A2:MWF 10:00 10:50Office:2-33Office Hours: Monday &amp; Wednesday 2: 00 3: 30 pmEmail:jjbone@ualberta.caSo much of the time we are
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2010Instructor: Jeffrey Bone, Barrister &amp; SolicitorLEC A3:MWF 11:00 11:50Office:2-33Office Hours: Monday &amp; Wednesday 2: 00 3: 30 pmEmail:jjbone@ualberta.caSo much of the time we are
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2011Instructor: Jeffrey Bone, Barrister &amp; SolicitorWebsite: http:/www.business.ualberta.ca/JeffreyBone.aspxOffice:1-27BOffice Hours: Monday 2: 15 3:30 pm (or by appointment)Do not hesit
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2011Instructor: Jeffrey Bone, Barrister &amp; SolicitorWebsite: http:/www.business.ualberta.ca/JeffreyBone.aspxOffice:1-27BOffice Hours: Monday 2: 15 3:30 pm (or by appointment)Do not hesit
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyFall 2011Instructor: Jeffrey Bone, Barrister &amp; SolicitorWebsite: http:/www.business.ualberta.ca/JeffreyBone.aspxOffice:1-27BOffice Hours: Monday 2: 15 3:30 pm (or by appointment)Do not hesit
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyWinter 2011Instructor: Jeffrey Bone, Barrister &amp; SolicitorOffice:2-33Office Hours: Monday 3: 00 4:30 pmDo not hesitate to come and see me during office hours, or you can email your questions
University of Alberta - BUS - 301
BUSINESS LAW 301Legal Foundations of the Canadian EconomyWinter 2011Instructor: Jeffrey Bone, Barrister &amp; SolicitorOffice:2-33Office Hours: Monday 3: 00 4:30 pmDo not hesitate to come and see me during office hours, or you can email your questions
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawFall 2000Course OutlineBUSINESS LAW 301, A1 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 0900 0950Class Room
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawTerm I, 2001/2002BUSINESS LAW 301, A1 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 9:00 9:50Class Room:HC L-
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawTerm I, 2001/2002BUSINESS LAW 301, A2 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 11:00 11:50Class Room:Bus
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawWINTER 2001Course OutlineBUSINESS LAW 301, B1 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 10:00 10:50Class
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawWINTER 2001Course OutlineBUSINESS LAW 301, B3 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 11:00 11:50Class
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics &amp; LawFall Term 2002BUSINESS LAW 301:A1 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 9:00-9:50Class Room:Bus 3-05O
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics &amp; LawFall Term 2002BUSINESS LAW 301:A2 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:MWF 11:00-11:50Class Room:Bus 1-05
University of Alberta - BUS - 301
University of AlbertaSchool of BusinessDepartment of Marketing, Business Economics &amp; LawFall Term 2002BUSINESS LAW 301:A3 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:Tuesday, Thursday 9:30-10:50Class R
University of Alberta - BUS - 301
University of AlbertaFaculty of BusinessDepartment of Marketing, Business Economics &amp; LawSpring Term 2002BUSINESS LAW 301 Legal Foundations of the Canadian EconomyCourse SyllabusInstructor:Douglas PetersonTime:T-Th 14:00 17:10Class Room:Bus 1-5